Ixchiq (VLA1553): The first FDA-approved vaccine to prevent disease caused by Chikungunya virus infection

被引：6
|
作者：
Ly, Hinh [1 ]
机构：
[1] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, Twin, MN 55455 USA
来源：
VIRULENCE | 2024年 / 15卷 / 01期
关键词：
Vaccine; chikungunya virus; CHIKV; Alphavirus; arbovirus; Ixchiq (VLA1553);
D O I：
10.1080/21505594.2023.2301573
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：2
相关论文
共 3 条
  • [1] From bench to clinic: the development of VLA1553/IXCHIQ, a live-attenuated chikungunya vaccine
    Chen, Lin H.
    Fritzer, Andrea
    Hochreiter, Romana
    Dubischar, Katrin
    Meyer, Stephanie
    [J]. JOURNAL OF TRAVEL MEDICINE, 2024,
  • [2] A randomized, double-blinded Phase 3 study to demonstrate lot-to-lot consistency and to confirm immunogenicity and safety of the live-attenuated chikungunya virus vaccine candidate VLA1553 in healthy adults
    Mcmahon, Robert
    Fuchs, Ulrike
    Schneider, Martina
    Hadl, Sandra
    Hochreiter, Romana
    Bitzer, Annegret
    Kosulin, Karin
    Koren, Michael
    Mader, Robert
    Zoihsl, Oliver
    Wressnigg, Nina
    Dubischar, Katrin
    Buerger, Vera
    Eder-Lingelbach, Susanne
    Jaramillo, Juan Carlos
    [J]. JOURNAL OF TRAVEL MEDICINE, 2024, 31 (02)
  • [3] The Approved Live-Attenuated Chikungunya Virus Vaccine (IXCHIQ®) Elicits Cross-Neutralizing Antibody Breadth Extending to Multiple Arthritogenic Alphaviruses Similar to the Antibody Breadth Following Natural Infection
    Weber, Whitney C.
    Streblow, Zachary J.
    Kreklywich, Craig N.
    Denton, Michael
    Sulgey, Gauthami
    Streblow, Magdalene M.
    Marcano, Dorca
    Flores, Paola N.
    Rodriguez-Santiago, Rachel M.
    Alvarado, Luisa I.
    Rivera-Amill, Vanessa
    Messer, William B.
    Hochreiter, Romana
    Kosulin, Karin
    Dubischar, Katrin
    Buerger, Vera
    Streblow, Daniel N.
    [J]. VACCINES, 2024, 12 (08)
1